493 related articles for article (PubMed ID: 17969036)
1. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
Ku NO; Strnad P; Zhong BH; Tao GZ; Omary MB
Hepatology; 2007 Nov; 46(5):1639-49. PubMed ID: 17969036
[TBL] [Abstract][Full Text] [Related]
2. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.
Ku NO; Soetikno RM; Omary MB
Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381
[TBL] [Abstract][Full Text] [Related]
3. Keratins: markers and modulators of liver disease.
Strnad P; Paschke S; Jang KH; Ku NO
Curr Opin Gastroenterol; 2012 May; 28(3):209-16. PubMed ID: 22450891
[TBL] [Abstract][Full Text] [Related]
4. The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury.
Hanada S; Strnad P; Brunt EM; Omary MB
Hepatology; 2008 Sep; 48(3):943-52. PubMed ID: 18697208
[TBL] [Abstract][Full Text] [Related]
5. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation.
Harada M; Strnad P; Resurreccion EZ; Ku NO; Omary MB
Hepatology; 2007 Jan; 45(1):88-96. PubMed ID: 17187412
[TBL] [Abstract][Full Text] [Related]
6. Keratin modifications and solubility properties in epithelial cells and in vitro.
Omary MB; Ku NO; Liao J; Price D
Subcell Biochem; 1998; 31():105-40. PubMed ID: 9932491
[TBL] [Abstract][Full Text] [Related]
7. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury.
Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB
J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
Strnad P; Harada M; Siegel M; Terkeltaub RA; Graham RM; Khosla C; Omary MB
Gastroenterology; 2007 Apr; 132(4):1515-26. PubMed ID: 17408647
[TBL] [Abstract][Full Text] [Related]
9. Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.
Guldiken N; Usachov V; Levada K; Trautwein C; Ziol M; Nahon P; Strnad P
Liver Int; 2015 Apr; 35(4):1203-12. PubMed ID: 24930437
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into changes in biochemical properties of keratins 8 and 18 in griseofulvin-induced toxic liver injury.
Fortier AM; Riopel K; Désaulniers M; Cadrin M
Exp Mol Pathol; 2010 Oct; 89(2):117-25. PubMed ID: 20643122
[TBL] [Abstract][Full Text] [Related]
11. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease.
Toivola DM; Ku NO; Resurreccion EZ; Nelson DR; Wright TL; Omary MB
Hepatology; 2004 Aug; 40(2):459-66. PubMed ID: 15368451
[TBL] [Abstract][Full Text] [Related]
12. Switch in Fas-activated death signaling pathway as result of keratin 8/18-intermediate filament loss.
Gilbert S; Ruel A; Loranger A; Marceau N
Apoptosis; 2008 Dec; 13(12):1479-93. PubMed ID: 19002587
[TBL] [Abstract][Full Text] [Related]
13. Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease.
Marceau N; Loranger A; Gilbert S; Daigle N; Champetier S
Biochem Cell Biol; 2001; 79(5):543-55. PubMed ID: 11716296
[TBL] [Abstract][Full Text] [Related]
14. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
Ku NO; Strnad P; Bantel H; Omary MB
Hepatology; 2016 Sep; 64(3):966-76. PubMed ID: 26853542
[TBL] [Abstract][Full Text] [Related]
15. Keratins modulate hepatic cell adhesion, size and G1/S transition.
Galarneau L; Loranger A; Gilbert S; Marceau N
Exp Cell Res; 2007 Jan; 313(1):179-94. PubMed ID: 17112511
[TBL] [Abstract][Full Text] [Related]
16. Keratin 8/18 regulation of glucose metabolism in normal versus cancerous hepatic cells through differential modulation of hexokinase status and insulin signaling.
Mathew J; Loranger A; Gilbert S; Faure R; Marceau N
Exp Cell Res; 2013 Feb; 319(4):474-86. PubMed ID: 23164509
[TBL] [Abstract][Full Text] [Related]
17. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity.
Zhong B; Strnad P; Selmi C; Invernizzi P; Tao GZ; Caleffi A; Chen M; Bianchi I; Podda M; Pietrangelo A; Gershwin ME; Omary MB
Hepatology; 2009 Aug; 50(2):546-54. PubMed ID: 19585610
[TBL] [Abstract][Full Text] [Related]
18. Liver disease-associated keratin 8 and 18 mutations modulate keratin acetylation and methylation.
Jang KH; Yoon HN; Lee J; Yi H; Park SY; Lee SY; Lim Y; Lee HJ; Cho JW; Paik YK; Hancock WS; Ku NO
FASEB J; 2019 Aug; 33(8):9030-9043. PubMed ID: 31199680
[TBL] [Abstract][Full Text] [Related]
19. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB
J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750
[TBL] [Abstract][Full Text] [Related]
20. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation.
Zhong B; Zhou Q; Toivola DM; Tao GZ; Resurreccion EZ; Omary MB
J Cell Sci; 2004 Apr; 117(Pt 9):1709-19. PubMed ID: 15075232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
